var data={"name":"Leukemia myeloproliferative disorders","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Acute lymphoblastic leukemia","type":"SUBSECTION","items":[{"name":"Clinical use of minimal residual disease detection in acute lymphoblastic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-use-of-minimal-residual-disease-detection-in-acute-lymphoblastic-leukemia"},{"name":"Cytogenetics and molecular genetics in acute lymphoblastic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cytogenetics-and-molecular-genetics-in-acute-lymphoblastic-leukemia"},{"name":"Detection of minimal residual disease in acute lymphoblastic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=detection-of-minimal-residual-disease-in-acute-lymphoblastic-leukemia"},{"name":"General principles of hematopoietic cell transplantation for acute lymphoblastic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-hematopoietic-cell-transplantation-for-acute-lymphoblastic-leukemia-in-adults"},{"name":"Induction therapy for Philadelphia chromosome negative acute lymphoblastic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=induction-therapy-for-philadelphia-chromosome-negative-acute-lymphoblastic-leukemia-in-adults"},{"name":"Induction therapy for Philadelphia chromosome positive acute lymphoblastic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=induction-therapy-for-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-in-adults"},{"name":"Overview of the outcome of acute lymphoblastic leukemia in children and adolescents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-outcome-of-acute-lymphoblastic-leukemia-in-children-and-adolescents"},{"name":"Overview of the presentation and diagnosis of acute lymphoblastic leukemia in children and adolescents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-presentation-and-diagnosis-of-acute-lymphoblastic-leukemia-in-children-and-adolescents"},{"name":"Overview of the treatment of acute lymphoblastic leukemia in children and adolescents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-acute-lymphoblastic-leukemia-in-children-and-adolescents"},{"name":"Post-remission therapy for Philadelphia chromosome negative acute lymphoblastic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=post-remission-therapy-for-philadelphia-chromosome-negative-acute-lymphoblastic-leukemia-in-adults"},{"name":"Post-remission therapy for Philadelphia chromosome positive acute lymphoblastic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=post-remission-therapy-for-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-in-adults"},{"name":"Risk group stratification and prognosis for acute lymphoblastic leukemia in children and adolescents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risk-group-stratification-and-prognosis-for-acute-lymphoblastic-leukemia-in-children-and-adolescents"},{"name":"Therapeutic use and toxicity of high-dose methotrexate","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=therapeutic-use-and-toxicity-of-high-dose-methotrexate"},{"name":"Treatment of relapsed or refractory acute lymphoblastic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-relapsed-or-refractory-acute-lymphoblastic-leukemia-in-adults"}]},{"name":"Acute myeloid leukemia","type":"SUBSECTION","items":[{"name":"Acute myeloid leukemia in children and adolescents","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acute-myeloid-leukemia-in-children-and-adolescents"},{"name":"Acute myeloid leukemia: Treatment and outcomes in older adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acute-myeloid-leukemia-treatment-and-outcomes-in-older-adults"},{"name":"Blastic plasmacytoid dendritic cell neoplasm","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=blastic-plasmacytoid-dendritic-cell-neoplasm"},{"name":"Classification of acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=classification-of-acute-myeloid-leukemia"},{"name":"Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-acute-myeloid-leukemia"},{"name":"Cytogenetics in acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cytogenetics-in-acute-myeloid-leukemia"},{"name":"Familial acute leukemia and myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=familial-acute-leukemia-and-myelodysplastic-syndromes"},{"name":"Hyperleukocytosis and leukostasis in hematologic malignancies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hyperleukocytosis-and-leukostasis-in-hematologic-malignancies"},{"name":"Induction therapy for acute myeloid leukemia in younger adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=induction-therapy-for-acute-myeloid-leukemia-in-younger-adults"},{"name":"Involvement of the central nervous system with acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=involvement-of-the-central-nervous-system-with-acute-myeloid-leukemia"},{"name":"Molecular genetics of acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=molecular-genetics-of-acute-myeloid-leukemia"},{"name":"Overview of acute myeloid leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-acute-myeloid-leukemia-in-adults"},{"name":"Overview of the complications of acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-complications-of-acute-myeloid-leukemia"},{"name":"Pathogenesis of acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-acute-myeloid-leukemia"},{"name":"Post-remission therapy for acute myeloid leukemia in younger adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=post-remission-therapy-for-acute-myeloid-leukemia-in-younger-adults"},{"name":"Pretreatment evaluation and prognosis of acute myeloid leukemia in older adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pretreatment-evaluation-and-prognosis-of-acute-myeloid-leukemia-in-older-adults"},{"name":"Prognosis of acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-of-acute-myeloid-leukemia"},{"name":"Remission criteria in acute myeloid leukemia and monitoring for residual disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=remission-criteria-in-acute-myeloid-leukemia-and-monitoring-for-residual-disease"},{"name":"Therapy-related myeloid neoplasms: Acute myeloid leukemia and myelodysplastic syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=therapy-related-myeloid-neoplasms-acute-myeloid-leukemia-and-myelodysplastic-syndrome"},{"name":"Treatment of relapsed or refractory acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-relapsed-or-refractory-acute-myeloid-leukemia"}]},{"name":"Acute promyelocytic leukemia","type":"SUBSECTION","items":[{"name":"Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-acute-promyelocytic-leukemia-in-adults"},{"name":"Initial treatment of acute promyelocytic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-treatment-of-acute-promyelocytic-leukemia-in-adults"},{"name":"Molecular biology of acute promyelocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=molecular-biology-of-acute-promyelocytic-leukemia"},{"name":"Treatment of relapsed or refractory acute promyelocytic leukemia in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-relapsed-or-refractory-acute-promyelocytic-leukemia-in-adults"}]},{"name":"Agnogenic myeloid metaplasia","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-primary-myelofibrosis"},{"name":"Management of primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-primary-myelofibrosis"},{"name":"Pathogenetic mechanisms in primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenetic-mechanisms-in-primary-myelofibrosis"},{"name":"Prognosis of primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-of-primary-myelofibrosis"}]},{"name":"Chronic lymphoproliferative disorders (including CLL)","type":"SUBSECTION","items":[{"name":"Chronic myelomonocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-myelomonocytic-leukemia"},{"name":"Clinical features and diagnosis of hairy cell leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-and-diagnosis-of-hairy-cell-leukemia"},{"name":"Clinical presentation, pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-pathologic-features-diagnosis-and-differential-diagnosis-of-chronic-lymphocytic-leukemia"},{"name":"Evaluating response to treatment of chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluating-response-to-treatment-of-chronic-lymphocytic-leukemia"},{"name":"Hematopoietic cell transplantation in chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematopoietic-cell-transplantation-in-chronic-lymphocytic-leukemia"},{"name":"Natural killer (NK) cell large granular lymphocyte leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=natural-killer-nk-cell-large-granular-lymphocyte-leukemia"},{"name":"Overview of the complications of chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-complications-of-chronic-lymphocytic-leukemia"},{"name":"Overview of the treatment of chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-chronic-lymphocytic-leukemia"},{"name":"Pathophysiology and genetic features of chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-and-genetic-features-of-chronic-lymphocytic-leukemia"},{"name":"Selection of initial therapy for symptomatic or advanced chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selection-of-initial-therapy-for-symptomatic-or-advanced-chronic-lymphocytic-leukemia"},{"name":"Staging and prognosis of chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=staging-and-prognosis-of-chronic-lymphocytic-leukemia"},{"name":"Treatment of T cell prolymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-t-cell-prolymphocytic-leukemia"},{"name":"Treatment of hairy cell leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-hairy-cell-leukemia"},{"name":"Treatment of large granular lymphocyte leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-large-granular-lymphocyte-leukemia"},{"name":"Treatment of relapsed or refractory chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-relapsed-or-refractory-chronic-lymphocytic-leukemia"}]},{"name":"Cytogenetics","type":"SUBSECTION","items":[{"name":"Chromosomal translocations, deletions, and inversions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chromosomal-translocations-deletions-and-inversions"},{"name":"Cytogenetics and molecular genetics of myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cytogenetics-and-molecular-genetics-of-myelodysplastic-syndromes"},{"name":"Cytogenetics in acute myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cytogenetics-in-acute-myeloid-leukemia"},{"name":"General aspects of cytogenetic analysis in hematologic malignancies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-aspects-of-cytogenetic-analysis-in-hematologic-malignancies"},{"name":"Genetic abnormalities in hematologic and lymphoid malignancies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=genetic-abnormalities-in-hematologic-and-lymphoid-malignancies"},{"name":"Pathophysiology and genetic features of chronic lymphocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathophysiology-and-genetic-features-of-chronic-lymphocytic-leukemia"},{"name":"Tools for genetics and genomics: Cytogenetics and molecular genetics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tools-for-genetics-and-genomics-cytogenetics-and-molecular-genetics"}]},{"name":"Essential thrombocythemia","type":"SUBSECTION","items":[{"name":"Diagnosis and clinical manifestations of essential thrombocythemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-clinical-manifestations-of-essential-thrombocythemia"},{"name":"Prognosis and treatment of essential thrombocythemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-and-treatment-of-essential-thrombocythemia"}]},{"name":"Myelodysplastic syndromes","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of the myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-the-myelodysplastic-syndromes"},{"name":"Cytogenetics and molecular genetics of myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cytogenetics-and-molecular-genetics-of-myelodysplastic-syndromes"},{"name":"Hematopoietic cell transplantation in myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematopoietic-cell-transplantation-in-myelodysplastic-syndromes"},{"name":"Idiopathic cytopenias of undetermined significance (ICUS), clonal hematopoiesis of indeterminate potential (CHIP), and clonal cytopenias of undetermined significance (CCUS)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=idiopathic-cytopenias-of-undetermined-significance-icus-clonal-hematopoiesis-of-indeterminate-potential-chip-and-clonal-cytopenias-of-undetermined-significance-ccus"},{"name":"Juvenile myelomonocytic leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=juvenile-myelomonocytic-leukemia"},{"name":"Management of the complications of the myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-the-complications-of-the-myelodysplastic-syndromes"},{"name":"Overview of the treatment of myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-myelodysplastic-syndromes"},{"name":"Prognosis of the myelodysplastic syndromes in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-of-the-myelodysplastic-syndromes-in-adults"},{"name":"Treatment of high or very high risk myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-high-or-very-high-risk-myelodysplastic-syndromes"},{"name":"Treatment of intermediate, low, or very low risk myelodysplastic syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-intermediate-low-or-very-low-risk-myelodysplastic-syndromes"}]},{"name":"Myeloproliferative disorders","type":"SUBSECTION","items":[{"name":"Cellular and molecular biology of chronic myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cellular-and-molecular-biology-of-chronic-myeloid-leukemia"},{"name":"Clinical manifestations and diagnosis of chronic myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-myeloid-leukemia"},{"name":"Clinical manifestations and diagnosis of polycythemia vera","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-polycythemia-vera"},{"name":"Clinical manifestations and diagnosis of primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-primary-myelofibrosis"},{"name":"Clinical use of tyrosine kinase inhibitors for chronic myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-use-of-tyrosine-kinase-inhibitors-for-chronic-myeloid-leukemia"},{"name":"Diagnosis and clinical manifestations of essential thrombocythemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-clinical-manifestations-of-essential-thrombocythemia"},{"name":"Hematopoietic cell transplantation in chronic myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematopoietic-cell-transplantation-in-chronic-myeloid-leukemia"},{"name":"Initial treatment of chronic myeloid leukemia in chronic phase","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-treatment-of-chronic-myeloid-leukemia-in-chronic-phase"},{"name":"Interferon alfa for the treatment of chronic myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=interferon-alfa-for-the-treatment-of-chronic-myeloid-leukemia"},{"name":"Management of primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-primary-myelofibrosis"},{"name":"Molecular genetics of chronic myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=molecular-genetics-of-chronic-myeloid-leukemia"},{"name":"Molecular pathogenesis of congenital polycythemic disorders and polycythemia vera","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=molecular-pathogenesis-of-congenital-polycythemic-disorders-and-polycythemia-vera"},{"name":"Overview of the myeloproliferative neoplasms","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-myeloproliferative-neoplasms"},{"name":"Overview of the treatment of chronic myeloid leukemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-chronic-myeloid-leukemia"},{"name":"Pathogenetic mechanisms in primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenetic-mechanisms-in-primary-myelofibrosis"},{"name":"Prognosis and treatment of polycythemia vera","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-and-treatment-of-polycythemia-vera"},{"name":"Prognosis of primary myelofibrosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-of-primary-myelofibrosis"},{"name":"Transient myeloproliferative disorder of Down syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=transient-myeloproliferative-disorder-of-down-syndrome"},{"name":"Treatment of chronic myeloid leukemia in accelerated phase","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-chronic-myeloid-leukemia-in-accelerated-phase"},{"name":"Treatment of chronic myeloid leukemia in blast crisis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-chronic-myeloid-leukemia-in-blast-crisis"},{"name":"Treatment of chronic myeloid leukemia in chronic phase after failure of initial therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-chronic-myeloid-leukemia-in-chronic-phase-after-failure-of-initial-therapy"}]},{"name":"Polycythemia vera","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of polycythemia vera","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-polycythemia-vera"},{"name":"Molecular pathogenesis of congenital polycythemic disorders and polycythemia vera","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=molecular-pathogenesis-of-congenital-polycythemic-disorders-and-polycythemia-vera"},{"name":"Prognosis and treatment of polycythemia vera","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prognosis-and-treatment-of-polycythemia-vera"}]}]}